Moderna advertising spend, FY2025

Moderna (MRNA) reported $133M of advertising expense for the fiscal year ended Dec 31, 2025. That is 6.8% of revenue of $1.9B. Down 8.9% from FY2024. Formerly Moderna Therapeutics.

Ad spend, FY2025
$133M
year ended Dec 31, 2025
Change vs prior year
-8.9%
vs FY2024
Share of revenue
6.8%
of $1.9B revenue
Rank by ad spend
#287
of 458 companies

Key facts

  • Ad spend is 1.1x its FY2022 level ($121M), faster than revenue (0.1x).
  • The highest year on file is FY2023 at $204M; FY2025 is 35% below it.
  • Largest increase +68.6% in FY2023; largest cut -28.4% in FY2024.
  • Ad spend has fallen 2 years in a row.
  • Moderna spends more on advertising than 37% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 1.5x the median of 4.5%.

Ad spend by fiscal year

$0 $100M $200M $300M FY2021 (ended 2021-12-31): $0 2021 FY2022 (ended 2022-12-31): $121M 2022 FY2023 (ended 2023-12-31): $204M 2023 FY2024 (ended 2024-12-31): $146M 2024 FY2025 (ended 2025-12-31): $133M 2025 $133M

Ad spend as % of revenue

0% 2% 4% 6% 8% FY2021 (ended 2021-12-31): 0.0% 2021 FY2022 (ended 2022-12-31): 0.6% 2022 FY2023 (ended 2023-12-31): 3.0% 2023 FY2024 (ended 2024-12-31): 4.5% 2024 FY2025 (ended 2025-12-31): 6.8% 2025 6.8%

Ad spend in context, FY2025

Research and development spending was 24x advertising. The company reported an operating loss of $3.1B.

Advertising $133M AdvertisingExpense
Research and development $3.1B R&D = 24x ad spend
Operating loss -$3.1B
Net loss -$2.8B

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $133M -8.9% $1.9B 6.8% AdvertisingExpense 10-K Feb 20, 2026
FY2024 Dec 31, 2024 $146M -28.4% $3.2B 4.5% AdvertisingExpense 10-K Feb 20, 2026
FY2023 Dec 31, 2023 $204M +68.6% $6.8B 3.0% AdvertisingExpense 10-K Feb 20, 2026
FY2022 Dec 31, 2022 $121M n/a $19.3B 0.6% AdvertisingExpense 10-K Feb 21, 2025
FY2021 Dec 31, 2021 $0 n/a $18.5B 0.0% AdvertisingExpense 10-K Feb 23, 2024

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank. A $0 value is what the filing tagged for that year.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Moderna in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
286 Steven Madden $134M 5.3% +31.0% FY2025
287 Moderna $133M 6.8% -8.9% FY2025
288 Penske Automotive Group $133M 0.4% -3.9% FY2025
289 Perrigo $133M 3.1% -1.2% FY2025
290 Helen of Troy $133M 7.4% -1.7% FY2026
291 Upbound Group $132M 2.8% +103.7% FY2025
292 Fiverr International $132M 30.6% +8.2% FY2025

Full ranking of 458 companies · Biggest cuts #50 · Ads above operating profit #96

Questions

How much does Moderna spend on advertising?

Moderna spent $133M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 20, 2026.

What percentage of revenue does Moderna spend on advertising?

6.8% of revenue in fiscal 2025 ($133M against $1.9B). The median across the 458 companies tracked is 4.5%.

Is Moderna spending more on advertising?

No. Ad spend fell 8.9% in fiscal 2025 from fiscal 2024. It has fallen 2 years in a row.

How does Moderna rank by advertising spend?

#287 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does Moderna spend more on advertising than on R&D?

No. In fiscal 2025 it spent $3.1B on research and development and $133M on advertising.

What does Moderna's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 20, 2026
Accession number
0001682852-26-000033
Company
Moderna, Inc., CIK 1682852, SIC 2836 (Biological Products, (No Diagnostic Substances))
Former names
Moderna Therapeutics
Headquarters
Cambridge, MA
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq
SEC filer status
Large accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
Moderna advertising spend, FY2021-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 20, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/moderna/advertising-spend/
Download
CSV, all years · CSV, all 458 companies